Why Altcoins Like Cardano Were Recovering on Saturday
Some thought the Crypto Winter was beginning to thaw.
2 Marijuana Stocks With Forward P/E Ratios Under 20
Yes, Virginia, there are profitable companies in the marijuana sector, and several can be bought at bargain-bin prices.
Why Altcoins Like Fantom and Litecoin Dived Today
The investor gloom fogging the Cryptosphere showed no sign of lifting at the end of the week.
Why Salesforce.com Stock Slipped on Friday
An analyst price target cut pushed the CRM specialist down on the day.
Why Bit Mining Stock Is Falling Hard This Week
Times are getting tough for crypto miners in one of the company's key global regions.
Why Zogenix Flew Higher Before Leveling Off This Week
The company attracts a determined suitor from abroad.
Why Novavax Stock Tumbled on Thursday
A new authorization from across the ocean fails to impress investors.
Why I'm Never Selling Digital Realty Trust
The company is one of only a few major operators in a very high-potential REIT segment.
Why SmileDirectClub Shot Nearly 5% Higher Today
Investors were heartened by news of a new teeth-whitening product.
Why Bank of America Climbed While the Market Fell Today
The company scored an encouraging beat on the bottom line in its latest reported quarter.
Why Axsome Therapeutics Climbed Today While the Market Fell
The stock receives a positive analyst thumbs-up after it issues a business update.
Why Apple Sank Along With the Stock Market Today
It's not the "A" tech stock investors were clamoring for on the day, plus there was some discouraging legal news for the company.
Why Bed Bath & Beyond Stock Dived by 9% Today
Not for the first time, an influential investment bank has trimmed its price target on the stock.
Is Realty Income's Dividend in Trouble?
The durably popular REIT operates in a sector battered by the pandemic, after all.
Why Marqeta Stock Tumbled More Than 5% Today
Another day, another analyst price-target cut.
Why Peloton Stock Flopped on Friday
The company is getting jettisoned from a prominent stock index.
Why Mirati Therapeutics Was Sinking This Week
A rival to the company's leading pipeline drug wins conditional marketing authorization in a big market abroad.
Why HealthEquity Stock Was Winning Big This Week
The company unveiled some highly encouraging growth statistics.
Why AMC Stock Got Stomped on Thursday
Investors reacted negatively to share sales by two top-level executives.
Why Pfizer and BioNTech Got Thrashed on Thursday
A fresh Supreme Court ruling does neither stock any favors.